Hancock Whitney Corp Reduces Holdings in Select Medical Holdings Co. (NYSE:SEM)

Hancock Whitney Corp cut its stake in Select Medical Holdings Co. (NYSE:SEM) by 4.6% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 9,162 shares of the health services provider’s stock after selling 445 shares during the period. Hancock Whitney Corp’s holdings in Select Medical were worth $276,000 as of its most recent SEC filing.

Other large investors also recently bought and sold shares of the company. GAMMA Investing LLC acquired a new stake in Select Medical during the 4th quarter worth $33,000. Fidelis Capital Partners LLC purchased a new stake in Select Medical during the 1st quarter valued at approximately $47,000. SG Americas Securities LLC acquired a new stake in Select Medical during the 1st quarter worth approximately $186,000. Allspring Global Investments Holdings LLC raised its stake in shares of Select Medical by 6.6% during the first quarter. Allspring Global Investments Holdings LLC now owns 6,563 shares of the health services provider’s stock worth $198,000 after purchasing an additional 405 shares during the last quarter. Finally, CreativeOne Wealth LLC acquired a new stake in shares of Select Medical during the first quarter worth $239,000. Institutional investors and hedge funds own 89.48% of the company’s stock.

Select Medical Price Performance

Shares of NYSE SEM traded down $3.98 on Friday, hitting $35.20. The company’s stock had a trading volume of 747,455 shares, compared to its average volume of 610,981. The company has a debt-to-equity ratio of 2.30, a current ratio of 1.22 and a quick ratio of 1.22. Select Medical Holdings Co. has a 12-month low of $21.28 and a 12-month high of $40.50. The company has a market capitalization of $4.58 billion, a price-to-earnings ratio of 16.38, a price-to-earnings-growth ratio of 1.81 and a beta of 1.43. The stock has a 50 day moving average of $35.75 and a 200-day moving average of $31.08.

Select Medical (NYSE:SEM) last announced its earnings results on Thursday, August 1st. The health services provider reported $0.60 earnings per share for the quarter, beating the consensus estimate of $0.59 by $0.01. Select Medical had a net margin of 3.97% and a return on equity of 18.11%. The firm had revenue of $1.76 billion during the quarter, compared to the consensus estimate of $1.74 billion. During the same quarter in the previous year, the company posted $0.61 EPS. The firm’s revenue for the quarter was up 5.1% on a year-over-year basis. As a group, research analysts predict that Select Medical Holdings Co. will post 2.19 EPS for the current year.

Analyst Upgrades and Downgrades

SEM has been the subject of several recent analyst reports. Benchmark raised their target price on shares of Select Medical from $42.00 to $48.00 and gave the stock a “buy” rating in a research note on Tuesday, July 16th. Royal Bank of Canada upped their target price on shares of Select Medical from $36.00 to $40.00 and gave the stock an “outperform” rating in a research report on Monday, May 6th. Two analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $36.50.

About Select Medical

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.